696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Kluwer university press
2020
|
| Subjects: | |
| Online Access: | http://eprints.uanl.mx/22445/1/22445.pdf |
| _version_ | 1824416529532321792 |
|---|---|
| author | Choueiri, T.K. Powles, T. Burotto, M. Bourlon, M.T. Zurawski, B. Oyervides Juárez, Víctor Manuel Hsieh, J.J. Basso, U. Shah, A.Y. Suarez, C. Hamzaj, A. Barrios, C.H. Richardet, M. Pook, D. Tomita, Y. Escudier, B. Zhang, J. Simsek, B. Apolo, A.B. Motzer, R.J. |
| author_facet | Choueiri, T.K. Powles, T. Burotto, M. Bourlon, M.T. Zurawski, B. Oyervides Juárez, Víctor Manuel Hsieh, J.J. Basso, U. Shah, A.Y. Suarez, C. Hamzaj, A. Barrios, C.H. Richardet, M. Pook, D. Tomita, Y. Escudier, B. Zhang, J. Simsek, B. Apolo, A.B. Motzer, R.J. |
| author_sort | Choueiri, T.K. |
| collection | Repositorio Institucional |
| format | Article |
| id | eprints-22445 |
| institution | UANL |
| language | English |
| publishDate | 2020 |
| publisher | Kluwer university press |
| record_format | eprints |
| spelling | eprints-224452024-03-05T20:51:42Z http://eprints.uanl.mx/22445/ 696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial Choueiri, T.K. Powles, T. Burotto, M. Bourlon, M.T. Zurawski, B. Oyervides Juárez, Víctor Manuel Hsieh, J.J. Basso, U. Shah, A.Y. Suarez, C. Hamzaj, A. Barrios, C.H. Richardet, M. Pook, D. Tomita, Y. Escudier, B. Zhang, J. Simsek, B. Apolo, A.B. Motzer, R.J. RC Medicina Interna, Psiquiatría, Neurología Kluwer university press 2020 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/22445/1/22445.pdf http://eprints.uanl.mx/22445/1.haspreviewThumbnailVersion/22445.pdf Choueiri, T.K. y Powles, T. y Burotto, M. y Bourlon, M.T. y Zurawski, B. y Oyervides Juárez, Víctor Manuel y Hsieh, J.J. y Basso, U. y Shah, A.Y. y Suarez, C. y Hamzaj, A. y Barrios, C.H. y Richardet, M. y Pook, D. y Tomita, Y. y Escudier, B. y Zhang, J. y Simsek, B. y Apolo, A.B. y Motzer, R.J. (2020) 696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial. Annals of oncology, 31 (S4). S1159. ISSN 0923-7534 http://doi.org/10.1016/j.annonc.2020.08.2257 doi:10.1016/j.annonc.2020.08.2257 |
| spellingShingle | RC Medicina Interna, Psiquiatría, Neurología Choueiri, T.K. Powles, T. Burotto, M. Bourlon, M.T. Zurawski, B. Oyervides Juárez, Víctor Manuel Hsieh, J.J. Basso, U. Shah, A.Y. Suarez, C. Hamzaj, A. Barrios, C.H. Richardet, M. Pook, D. Tomita, Y. Escudier, B. Zhang, J. Simsek, B. Apolo, A.B. Motzer, R.J. 696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial |
| thumbnail | https://rediab.uanl.mx/themes/sandal5/images/online.png |
| title | 696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial |
| title_full | 696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial |
| title_fullStr | 696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial |
| title_full_unstemmed | 696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial |
| title_short | 696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial |
| title_sort | 696o pr nivolumab cabozantinib vs sunitinib in first line treatment for advanced renal cell carcinoma first results from the randomized phase iii checkmate 9er trial |
| topic | RC Medicina Interna, Psiquiatría, Neurología |
| url | http://eprints.uanl.mx/22445/1/22445.pdf |
| work_keys_str_mv | AT choueiritk 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT powlest 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT burottom 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT bourlonmt 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT zurawskib 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT oyervidesjuarezvictormanuel 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT hsiehjj 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT bassou 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT shahay 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT suarezc 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT hamzaja 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT barriosch 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT richardetm 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT pookd 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT tomitay 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT escudierb 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT zhangj 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT simsekb 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT apoloab 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial AT motzerrj 696oprnivolumabcabozantinibvssunitinibinfirstlinetreatmentforadvancedrenalcellcarcinomafirstresultsfromtherandomizedphaseiiicheckmate9ertrial |